8 assets in Injury

Therapeutic assets addressing Injury, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Tranexamic Acid Injury	Daniel Nishijima, MD, MAS	P3	BB (66)
Epoetin Alfa Injury	Australian and New Zealand Intensive Care Research Centre	P3	B (60)
Lidocaine Injury	Instituto Nacional de Cancer, Brazil	P2	CCC (53)
Nepenthe Injury	Instituto Nacional de Cancer, Brazil	P2	CCC (53)
Aspirin Injury	London Health Sciences Centre	Early P1	NR ()
Ketorolac Injury	Massachusetts General Hospital	P4	NR ()